Early Detection and the Future of Care | Jani Tuomi, Serial Health Tech Founder & Investor
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Early Detection and the Future of Care | Jani Tuomi, Serial Health Tech Founder & Investor
-
ナレーター：
-
著者：
His brother was misdiagnosed for over a year while cancer spread. One blood test could have caught it. That experience pulled Jani Tuomi out of fintech and into healthcare, where he co-founded Imaware, one of the first companies to bring lab-grade autoimmune and cardiovascular screening to your home with a finger prick. He has since helped build companies across ALS therapeutics, neurotechnology, and physician workforce, including Coya Therapeutics, Coherence Neuro, and Matchday Health.
We talk about the difference between screening and diagnosing, what to look for before you trust an at-home health test, and why your doctor might throw out results that don't meet a specific standard.
Jani now invests in early-stage health tech founders in Austin, co-authors the Austin Bio and Health Report, and is working to make the city a national leader in health innovation.
If you have ever wanted more answers about your own health than you were getting, this one is for you.